蓝丰生化
(002513)
| 流通市值：11.08亿 | | | 总市值：15.76亿 |
| 流通股本：2.64亿 | | | 总股本：3.75亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,426,638,363.1 | 849,051,865.51 | 378,109,304.42 | 1,741,628,407.17 |
| 营业收入 | 1,426,638,363.1 | 849,051,865.51 | 378,109,304.42 | 1,741,628,407.17 |
| 二、营业总成本 | 1,643,457,446.3 | 996,672,441.73 | 440,095,408.26 | 1,995,210,645.31 |
| 营业成本 | 1,441,191,157.64 | 869,751,953.42 | 373,444,033.32 | 1,777,324,275.09 |
| 利息支出 | 11,022,554.45 | - | - | - |
| 税金及附加 | - | 3,829,630.01 | 1,524,138.14 | 7,649,297.49 |
| 销售费用 | 32,725,354.49 | 22,094,028.66 | 8,809,251.58 | 25,213,902.95 |
| 管理费用 | 65,910,801.92 | 48,355,445.72 | 20,839,691.39 | 142,741,412.46 |
| 研发费用 | 59,544,277.01 | 37,889,370.76 | 27,074,326.9 | 15,256,020.56 |
| 财务费用 | 33,063,300.79 | 14,752,013.16 | 8,403,966.93 | 27,025,736.76 |
| 其中:利息费用 | 33,046,125.53 | 18,955,416.21 | - | 26,533,945.4 |
| 其中:利息收入 | 4,062,079.41 | 2,810,084.98 | - | 1,010,515.08 |
| 加:投资收益 | 428,549.46 | 621,010.7 | - | 31,616,108.97 |
| 资产处置收益 | -358,326.75 | -261,610.47 | - | -1,464,602.37 |
| 资产减值损失(新) | -38,004,613.44 | -29,519,919.52 | -106,776.38 | -118,867,143.84 |
| 信用减值损失(新) | -30,567,285.49 | -29,341,371.2 | -1,648,683.16 | -12,943,081.84 |
| 其他收益 | 14,162,796.69 | 5,850,494.44 | 7,108,985.58 | 8,569,064.67 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -271,157,962.73 | -200,271,972.27 | -56,632,577.8 | -346,671,892.55 |
| 加:营业外收入 | 1,208,056.61 | 650,956.72 | 0.05 | 3,268,246.99 |
| 减:营业外支出 | 32,222,296.96 | 26,013,134.78 | 6,286.7 | 10,929,367.48 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -302,172,203.08 | -225,634,150.33 | -56,638,864.45 | -354,333,013.04 |
| 减:所得税费用 | -57,298,382.32 | -48,121,458.39 | -14,159,716.12 | -6,596,776.75 |
| 六、净利润 | -244,873,820.76 | -177,512,691.94 | -42,479,148.33 | -347,736,236.29 |
| 持续经营净利润 | -244,873,820.76 | -177,512,691.94 | -42,479,148.33 | -347,736,236.29 |
| 归属于母公司股东的净利润 | -185,030,513.69 | -139,369,184.81 | -30,509,968.18 | -332,260,445.98 |
| 少数股东损益 | -59,843,307.07 | -38,143,507.13 | -11,969,180.15 | -15,475,790.31 |
| (一)基本每股收益 | -0.51 | -0.39 | -0.08 | -0.89 |
| (二)稀释每股收益 | -0.51 | -0.39 | -0.08 | -0.89 |
| 八、其他综合收益 | 120,107.14 | 120,107.14 | - | 272,428.91 |
| 归属于母公司股东的其他综合收益 | 120,107.14 | 120,107.14 | - | 272,428.91 |
| 九、综合收益总额 | -244,753,713.62 | -177,392,584.8 | -42,479,148.33 | -347,463,807.38 |
| 归属于母公司股东的综合收益总额 | -184,910,406.55 | -139,249,077.67 | -30,509,968.18 | -331,988,017.07 |
| 归属于少数股东的综合收益总额 | -59,843,307.07 | -38,143,507.13 | -11,969,180.15 | -15,475,790.31 |
| 公告日期 | 2024-10-31 | 2024-08-06 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |